Abraham Ceesay
Chief Executive Officer at RAPP; Director at PCRX; President at Cerevel Therapeutics Holdings, Inc.
Filed with the SEC as Ceesay Abraham
- Sold, on record
- $11.6M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Oct 21, 2026
- Form 144 notices
- 11
- Proposed sales
- Quarters with a sale
- 6 of the last 8
- 16 days with a sale in that time
- Companies
- 3
- Filed as an executive or holder
Companies
- RAPPRapport Therapeutics, Inc.Chief Executive Officer
- PCRXPacira BioSciences, Inc.Director
- Cerevel Therapeutics Holdings, Inc.President
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- RAPP237,212 shares
- Cerevel Therapeutics Holdings, Inc.96,056 shares
- PCRX2,354 shares
Shares sold, every Form 4 sale on record.
Timeline
- Oct 21, 2026Routine
Sold 0.5% of their holdings
$64k2,210 shares at $29.16
- Oct 7, 2026Routine
Sold 1% of their holdings
$143k4,522 shares at $31.68
- Oct 6, 2026Notice
Filed a notice to sell 39,470 shares
$1.2M39,470 shares
- Sep 23, 2026Routine
Sold 0.5% of their holdings
$87k2,210 shares at $39.17
- Sep 8, 2026Routine
Sold 1.8% of their holdings
$375k8,210 shares at $45.62
- Aug 25, 2026Routine
Sold 3.9% of their holdings
$938k18,921 shares at $49.57
- Aug 11, 2026Unusual
Sold 9.6% of their holdings
$2.4M51,499 shares at $47.24
- Jul 27, 2026Routine
Sold 0.4% of their holdings
$93k2,210 shares at $42.11
- Jul 14, 2026Routine
Sold 1.5% of their holdings
$328k8,210 shares at $40.00
- Jun 29, 2026Routine
Sold 1.5% of their holdings
$327k8,220 shares at $39.83
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | Oct 23, 2026 | RAPP | Chief Executive Officer | Sold | 2,210 | $29.16 | $64k | 450,035 | SEC |
| Oct 7, 2026 | Oct 8, 2026 | RAPP | Chief Executive Officer | Sold | 4,522 | $31.68 | $143k | 452,245 | SEC |
| Sep 23, 2026 | Sep 24, 2026 | RAPP | Chief Executive Officer | Sold | 2,210 | $39.17 | $87k | 456,767 | SEC |
| Sep 8, 2026 | Sep 9, 2026 | RAPP | Chief Executive Officer | Sold | 8,210 | $45.62 | $375k | 458,977 | SEC |
| Aug 25, 2026 | Aug 26, 2026 | RAPP | Chief Executive Officer | Sold | 18,921 | $49.57 | $938k | 467,187 | SEC |
| Aug 11, 2026 | Aug 12, 2026 | RAPP | Chief Executive Officer | Sold | 51,499 | $47.24 | $2.4M | 486,108 | SEC |
| Jul 27, 2026 | Jul 29, 2026 | RAPP | Chief Executive Officer | Sold | 2,210 | $42.11 | $93k | 537,607 | SEC |
| Jul 14, 2026 | Jul 15, 2026 | RAPP | Chief Executive Officer | Sold | 8,210 | $40.00 | $328k | 539,817 | SEC |
| Jun 29, 2026 | Jul 1, 2026 | RAPP | Chief Executive Officer | Sold | 8,220 | $39.83 | $327k | 548,027 | SEC |
| May 8, 2026 | May 11, 2026 | CRL | Director | Awarded | 1,438 | $177.62 | $255k | 2,384 | SEC |
| Feb 18, 2026 | Feb 19, 2026 | RAPP | Chief Executive Officer | Sold | 10,916 | $29.35 | $320k | 20,729 | SEC |
| Feb 2, 2026 | Feb 4, 2026 | RAPP | Chief Executive Officer | AwardedStock Option (Right to Buy) | 428,000 | 428,000 | SEC | ||
| Jan 20, 2026 | Jan 22, 2026 | RAPP | Chief Executive Officer | Sold | 10,916 | $26.12 | $285k | 25,812 | SEC |
| Dec 17, 2025 | Dec 18, 2025 | RAPP | Chief Executive Officer | Sold | 10,916 | $29.64 | $324k | 30,895 | SEC |
| Nov 17, 2025 | Nov 18, 2025 | RAPP | Chief Executive Officer | Sold | 10,916 | $25.20 | $275k | 35,978 | SEC |
| Oct 15, 2025 | Oct 16, 2025 | RAPP | Chief Executive Officer | Sold | 10,916 | $25.81 | $282k | 41,061 | SEC |
| Sep 17, 2025 | Sep 19, 2025 | RAPP | Chief Executive Officer | Sold | 76,420 | $26.32 | $2M | 46,144 | SEC |
| Sep 4, 2025 | Sep 8, 2025 | PCRX | Director | Sold | 2,354 | $27.19 | $64k | 9,039 | SEC |
| Jun 11, 2025 | Jun 13, 2025 | PCRX | Director | AwardedStock Option (Right to Buy) | 11,279 | 11,279 | SEC | ||
| Jun 11, 2025 | Jun 13, 2025 | PCRX | Director | Awarded | 6,163 | 11,393 | SEC | ||
| Jun 2, 2025 | Jun 4, 2025 | CRL | Director | AwardedStock Options (Right to Buy) | 2,082 | $135.04 | $281k | 2,082 | SEC |
| Jun 2, 2025 | Jun 4, 2025 | CRL | Director | Awarded | 946 | $135.04 | $128k | 946 | SEC |
| Feb 3, 2025 | Feb 4, 2025 | RAPP | Chief Executive Officer | AwardedStock Option (Right to Buy) | 428,000 | 428,000 | SEC | ||
| Jun 12, 2024 | Jun 13, 2024 | PCRX | Director | AwardedStock Option (Right to Buy) | 12,179 | 12,179 | SEC | ||
| Jun 12, 2024 | Jun 13, 2024 | PCRX | Director | Awarded | 5,230 | 5,230 | SEC | ||
| Jun 6, 2024 | Jun 10, 2024 | RAPP | Chief Executive Officer | AwardedStock Option (Right to Buy) | 530,647 | 530,647 | SEC | ||
| Oct 6, 2023 | Oct 11, 2023 | PCRX | Director | AwardedStock Option (Right to Buy) | 30,967 | 30,967 | SEC | ||
| Feb 6, 2023 | Feb 8, 2023 | Cerevel Therapeutics Holdings, Inc. | President | AwardedStock Option (Right to Buy) | 143,528 | 29,083 | SEC | ||
| Sep 8, 2022 | Sep 12, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Sold | 19,210 | $32.50 | $624k | 0 | SEC |
| Sep 8, 2022 | Sep 12, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Exercised or settledStock Option (Right to Buy) | 19,210 | 365,009 | SEC | ||
| Sep 8, 2022 | Sep 12, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Exercised options | 19,210 | $13.17 | $253k | 19,210 | SEC |
| Aug 22, 2022 | Aug 24, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Sold | 9,605 | $32.50 | $312k | 0 | SEC |
| Aug 22, 2022 | Aug 24, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Exercised or settledStock Option (Right to Buy) | 9,605 | 384,219 | SEC | ||
| Aug 22, 2022 | Aug 24, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Exercised options | 9,605 | $13.17 | $126k | 9,605 | SEC |
| Aug 15, 2022 | Aug 17, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Sold | 9,606 | $34.12 | $328k | 0 | SEC |
| Aug 15, 2022 | Aug 17, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Exercised or settledStock Option (Right to Buy) | 9,606 | 393,824 | SEC | ||
| Aug 15, 2022 | Aug 17, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Exercised options | 9,606 | $13.17 | $127k | 9,606 | SEC |
| Aug 8, 2022 | Aug 9, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Sold | 57,635 | $34.54 | $2M | 0 | SEC |
| Aug 8, 2022 | Aug 9, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Exercised or settledStock Option (Right to Buy) | 57,635 | 403,430 | SEC | ||
| Aug 8, 2022 | Aug 9, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Exercised options | 57,635 | $13.17 | $759k | 19,211 | SEC |
| Feb 9, 2022 | Feb 11, 2022 | Cerevel Therapeutics Holdings, Inc. | President | AwardedStock Option (Right to Buy) | 120,310 | 120,310 | SEC | ||
| Jun 1, 2021 | Jun 3, 2021 | Cerevel Therapeutics Holdings, Inc. | President | AwardedStock Option (Right to Buy) | 461,065 | 461,065 | SEC | ||
| Jan 17, 2018 | Jan 19, 2018 | scPharmaceuticals Inc. | Chief Operating Officer | AwardedStock Option (Right to Buy) | 80,971 | 80,971 | SEC |
Sales and notices (31)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | Oct 23, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 2,210 | $64k | 0.5% | Routine | SEC |
| Oct 7, 2026 | Oct 8, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 4,522 | $143k | 1.0% | Routine | SEC |
| Oct 6, 2026 | Oct 6, 2026 | RAPP | Chief Executive Officer | Form 144 notice | 39,470 | $1.2M | Notice | SEC | |
| Sep 23, 2026 | Sep 24, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 2,210 | $87k | 0.5% | Routine | SEC |
| Sep 8, 2026 | Sep 9, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 8,210 | $375k | 1.8% | Routine | SEC |
| Aug 25, 2026 | Aug 26, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 18,921 | $938k | 3.9% | Routine | SEC |
| Aug 11, 2026 | Aug 12, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 51,499 | $2.4M | 9.6% | Unusual | SEC |
| Jul 27, 2026 | Jul 29, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 2,210 | $93k | 0.4% | Routine | SEC |
| Jul 14, 2026 | Jul 15, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 8,210 | $328k | 1.5% | Routine | SEC |
| Jun 29, 2026 | Jul 1, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 8,220 | $327k | 1.5% | Routine | SEC |
| Jun 29, 2026 | Jun 29, 2026 | RAPP | Chief Executive Officer | Form 144 notice | 99,480 | $4M | Notice | SEC | |
| Jun 12, 2026 | Jun 12, 2026 | PCRX | Director | Form 144 notice | 9,039 | $210k | Notice | SEC | |
| Feb 18, 2026 | Feb 19, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 10,916 | $320k | 1.9% | Routine | SEC |
| Jan 20, 2026 | Jan 22, 2026 | RAPP | Chief Executive Officer | Form 4 sale | 10,916 | $285k | 1.9% | Routine | SEC |
| Dec 17, 2025 | Dec 18, 2025 | RAPP | Chief Executive Officer | Form 4 sale | 10,916 | $324k | 1.9% | Routine | SEC |
| Dec 17, 2025 | Dec 17, 2025 | RAPP | Chief Executive Officer | Form 144 notice | 15,249 | $469k | Notice | SEC | |
| Dec 17, 2025 | Dec 17, 2025 | RAPP | Chief Executive Officer | Form 144 notice | 17,499 | $538k | Notice | SEC | |
| Nov 17, 2025 | Nov 18, 2025 | RAPP | Chief Executive Officer | Form 4 sale | 10,916 | $275k | 1.9% | Routine | SEC |
| Oct 15, 2025 | Oct 16, 2025 | RAPP | Chief Executive Officer | Form 4 sale | 10,916 | $282k | 1.8% | Routine | SEC |
| Sep 17, 2025 | Sep 19, 2025 | RAPP | Chief Executive Officer | Form 4 sale | 76,420 | $2M | 11.5% | Routine | SEC |
| Sep 17, 2025 | Sep 17, 2025 | RAPP | Chief Executive Officer | Form 144 notice | 52,501 | $1.4M | Notice | SEC | |
| Sep 17, 2025 | Sep 17, 2025 | RAPP | Chief Executive Officer | Form 144 notice | 45,751 | $1.2M | Notice | SEC | |
| Sep 4, 2025 | Sep 8, 2025 | PCRX | Director | Form 4 sale | 2,354 | $64k | 20.7% | Routine | SEC |
| Sep 4, 2025 | Sep 4, 2025 | PCRX | Director | Form 144 notice | 2,354 | $64k | Notice | SEC | |
| May 8, 2023 | May 8, 2023 | Cerevel Therapeutics Holdings, Inc. | President | Form 144 notice | 35,219 | $1.1M | Notice | SEC | |
| May 5, 2023 | May 5, 2023 | Cerevel Therapeutics Holdings, Inc. | President | Form 144 notice | 35,220 | $1.1M | Notice | SEC | |
| May 4, 2023 | May 4, 2023 | Cerevel Therapeutics Holdings, Inc. | President | Form 144 notice | 35,220 | $1.1M | Notice | SEC | |
| Sep 8, 2022 | Sep 12, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Form 4 sale | 19,210 | $624k | 100.0% | Unusual | SEC |
| Aug 22, 2022 | Aug 24, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Form 4 sale | 9,605 | $312k | 100.0% | Unusual | SEC |
| Aug 15, 2022 | Aug 17, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Form 4 sale | 9,606 | $328k | 100.0% | Unusual | SEC |
| Aug 8, 2022 | Aug 9, 2022 | Cerevel Therapeutics Holdings, Inc. | President | Form 4 sale | 57,635 | $2M | 100.0% | Unusual | SEC |